HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief

This article was originally published in The Rose Sheet

Executive Summary

Synoia Technologies seeks “fastest” status for its anti-aging aesthetic device, P&G recalls select Crest & Scope oral-rinse products and Avon finishes refinancing. More news in brief.

You may also be interested in...

Avon Announces More Layoffs, Plans To Exit Ireland

As part of Avon Products Inc.’s previously announced $400 million Cost Saving Initiative, the firm has announced plans to exit Ireland and eliminate 400 positions globally, among other measures.

Unilever Lynx Ads Harmful To Children, Offensive To Women, Says U.K. Authority

The U.K.’s advertising watchdog says that recent ads for Unilever’s Lynx brand deodorants and Lynx Excite shower gel breach advertising code, objectify women and are not appropriate for children to view. The ads must not appear again in their current form.

Unilever Called Out For “Hypocrisy” Of Conflicting Dove, Axe Ad Campaigns

Unilever has come under fire for the seemingly contrary messages of Dove and Axe, two of its biggest brands and most buzzed-about advertising campaigns

Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts